| Literature DB >> 26051935 |
Peng Liu1, Miranda N Reed1, Linda A Kotilinek1, Marianne K O Grant1, Colleen L Forster2, Wei Qiang3, Samantha L Shapiro1, John H Reichl1, Angie C A Chiang4, Joanna L Jankowsky4, Carrie M Wilmot5, James P Cleary6, Kathleen R Zahs1, Karen H Ashe7.
Abstract
The accumulation of amyloid-β (Aβ) as amyloid fibrils and toxic oligomers is an important step in the development of Alzheimer's disease (AD). However, there are numerous potentially toxic oligomers and little is known about their neurological effects when generated in the living brain. Here we show that Aβ oligomers can be assigned to one of at least two classes (type 1 and type 2) based on their temporal, spatial, and structural relationships to amyloid fibrils. The type 2 oligomers are related to amyloid fibrils and represent the majority of oligomers generated in vivo, but they remain confined to the vicinity of amyloid plaques and do not impair cognition at levels relevant to AD. Type 1 oligomers are unrelated to amyloid fibrils and may have greater potential to cause global neural dysfunction in AD because they are dispersed. These results refine our understanding of the pathogenicity of Aβ oligomers in vivo.Entities:
Mesh：
Substances：
Year: 2015 PMID： 26051935 PMCID： PMC4494129 DOI： 10.1016/j.celrep.2015.05.021
Source DB: PubMed Journal: Cell Rep Impact factor: 9.423